BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35805203)

  • 21. Prognostic factors and genes associated with endometrial cancer based on gene expression profiling by bioinformatics analysis.
    Zhang Y; Zhang W; Li X; Li D; Zhang X; Yin Y; Deng X; Sheng X
    Arch Gynecol Obstet; 2016 Jun; 293(6):1287-95. PubMed ID: 26437953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A serum lipidomics study for the identification of specific biomarkers for endometrial polyps to distinguish them from endometrial cancer or hyperplasia.
    Yan X; Zhao W; Wei J; Yao Y; Sun G; Wang L; Zhang W; Chen S; Zhou W; Zhao H; Li X; Xiao Y; Li Y
    Int J Cancer; 2022 May; 150(9):1549-1559. PubMed ID: 35076938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
    Yang Q; Yu B; Sun J
    Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competing endogenous RNA network of endometrial carcinoma: A comprehensive analysis.
    Liu J; Nie S; Liang J; Jiang Y; Wan Y; Zhou S; Cheng W
    J Cell Biochem; 2019 Sep; 120(9):15648-15660. PubMed ID: 31056798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress.
    Monge M; Colas E; Doll A; Gil-Moreno A; Castellvi J; Diaz B; Gonzalez M; Lopez-Lopez R; Xercavins J; Carreras R; Alameda F; Canals F; Gabrielli F; Reventos J; Abal M
    Carcinogenesis; 2009 Aug; 30(8):1288-97. PubMed ID: 19443906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia is involved in the reduction of HtrA3 in patients with endometrial hyperplasia and cancer.
    Lv Q; Yang B; Ning C; Xie B; Nie G; Chen X; Chen Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2918-2923. PubMed ID: 30139517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.
    He S; Zeng S; Zhou ZW; He ZX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioinformatics analysis of key differentially expressed genes in well and poorly differentiated endometrial carcinoma.
    Zang Y; Dong M; Zhang K; Tian W; Wang Y; Xue F
    Mol Med Rep; 2018 Jul; 18(1):467-476. PubMed ID: 29749513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic analysis of stage I endometrial cancer tissue: identification of proteins associated with oxidative processes and inflammation.
    Maxwell GL; Hood BL; Day R; Chandran U; Kirchner D; Kolli VS; Bateman NW; Allard J; Miller C; Sun M; Flint MS; Zahn C; Oliver J; Banerjee S; Litzi T; Parwani A; Sandburg G; Rose S; Becich MJ; Berchuck A; Kohn E; Risinger JI; Conrads TP
    Gynecol Oncol; 2011 Jun; 121(3):586-94. PubMed ID: 21458040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A metabolomic signature of FIGO stage I and II endometrial cancer.
    Gu M; Chen X; Sun Y; Wang L; Shu H; Qian C
    Neoplasma; 2021 Nov; 68(6):1283-1291. PubMed ID: 34689564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
    Davalieva K; Kostovska IM; Kiprijanovska S; Markoska K; Kubelka-Sabit K; Filipovski V; Stavridis S; Stankov O; Komina S; Petrusevska G; Polenakovic M
    Prostate; 2015 Oct; 75(14):1586-600. PubMed ID: 26074449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Key Prognostic-Related miRNA-mRNA Pairs in the Progression of Endometrial Carcinoma.
    Dong Y; Zhang T; Li X; Yu F; Yu H; Shao S
    Gynecol Obstet Invest; 2022; 87(1):12-21. PubMed ID: 35081534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-Omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer.
    Yi R; Xie L; Wang X; Shen C; Chen X; Qiao L
    Front Oncol; 2022; 12():861142. PubMed ID: 35574395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic characterization of peroxisome proliferator-activated receptor-γ (PPARγ) overexpressing or silenced colorectal cancer cells unveils a novel protein network associated with an aggressive phenotype.
    Milone MR; Pucci B; Colangelo T; Lombardi R; Iannelli F; Colantuoni V; Sabatino L; Budillon A
    Mol Oncol; 2016 Oct; 10(8):1344-62. PubMed ID: 27499265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteomics reveals protein profile changes in cyclooxygenase-2 inhibitor-treated endometrial cancer cells.
    Yi Z; Jingting C; Yu Z
    Int J Gynecol Cancer; 2009 Apr; 19(3):326-33. PubMed ID: 19407554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in endometrial cancer protein biomarkers for use in the clinic.
    Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
    Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DJ-1 in endometrial cancer: a possible biomarker to improve differential diagnosis between subtypes.
    Morelli M; Scumaci D; Di Cello A; Venturella R; Donato G; Faniello MC; Quaresima B; Cuda G; Zullo F; Costanzo F
    Int J Gynecol Cancer; 2014 May; 24(4):649-58. PubMed ID: 24614826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EXPRESSION LEVELS OF FOXO-1, P27KIP1, MIR-27, MIR-186 AND AKT1/AKT-P PROTEINS IN WOMEN WITH ENDOMETRIAL CANCER AND HYPERPLASIA: IMPLICATIONS FOR THE HUMAN REPRODUCTIVE SYSTEM.
    Ghaderi P; Fallah S; Khaledi HR; Tehranian A; Rahmati F; Sheikhhasani S
    Acta Endocrinol (Buchar); 2023; 19(1):1-9. PubMed ID: 37601705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
    Ghazanfar S; Fatima I; Aslam M; Musharraf SG; Sherman NE; Moskaluk C; Fox JW; Akhtar MW; Sadaf S
    J Proteomics; 2017 Jan; 152():33-40. PubMed ID: 27989943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.